LETTERS TO THE EDITORTurk J Hematol 2020;37:125-138Comprehensive research has been done on myeloid neoplasmsrelated to pediatric DS; we now emphasize the importance ofreporting similar findings in adult patients, so as to be able tobetter delineate the course and subsequent management of thisunder-recognized condition in later life.Keywords: Adult, Down syndrome, Myelodysplastic syndromeAnahtar Sözcükler: Yetişkin, Down sendrom, MyelodisplastiksendromInformed Consent: Informed consent was obtained from thepatient included in the study.Authorship ContributionsData Collection or Processing: H.V.; Literature Search: H.V., S.N.;Writing: H.V., S.N.Conflict of Interest: We confirm that there are no conflicts ofinterest to declare.References1. Fong CT, Bordeur GM. Down’s syndrome and leukemia: epidemiology,genetics, cytogenetics and mechanisms of leukemogenesis. Cancer GenetCytogenet 1987;28:55-76.2. Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH.The changing survival profile of people with Down’s syndrome: implicationsfor genetic counselling. Clin Genet 2002;62:390-393.3. Carfì A, Antocicco M, Brandi V, Cipriani C, Fiore F, Mascia D, Settanni S,Vetrano DL, Bernabei R, Onder G. Characteristics of adults with Downsyndrome: prevalence of age-related conditions. Front Med (Lausanne)2014;1:51.4. De Benedittis D, Fianchi L, Niscola P, Piccioni A, Di Veroli A, Campagna A,Mancini S, Villiva N, Mohamed S, Carmosino I, Criscuolo M, Fenu S, AloeSpiriti MA, Buccisano F, Breccia M, Mancini M, Latagliata R. Myelodysplasticsyndromes with isolated 20q deletion: a new clinical-biological entity?Blood 2018;132(Suppl 1):5516.5. McLean S, McHale C, Enright H. Hematological abnormalities in adultpatients with Down’s syndrome. Ir J Med Sci 2009;178:35-38.©Copyright 2020 by Turkish Society of HematologyTurkish Journal of Hematology, Published by Galenos Publishing HouseAddress for Correspondence/Yazışma Adresi: Shano Naseem, M.D., Postgraduate Institute of MedicalEducation and Research, Department of Hematology, Chandigarh, IndiaPhone : 91-172-2755131E-mail : shanonaseem@yahoo.co.in ORCID: orcid.org/0000-0003-0580-019XReceived/Geliş tarihi: November 8, 2019Accepted/Kabul tarihi: February 13, 2020DOI: 10.4274/tjh.galenos.2020.2019.0397138
Advisory Board of This Issue (June 2020)Atoosa Gharib, IranAydan Akdeniz, TurkeyAyşe Çırakoğlu, TurkeyBarbara J. Bain, United KingdomBela Balint, SerbiaBrenda W. Cooper, USACan Boğa, TurkeyDavut Albayrak, TurkeyDeniz Karapınar, TurkeyEbru Koca, TurkeyElias Kouroumalis, GreeceEvren Özdemir, TurkeyFatma Burcu Belen Apak, TurkeyGiuseppe Visani, ItalyHakan Göker, TurkeyInes Lohse, USAİrfan Yavaşoğlu, TurkeyJuan Manuel Mejia-Arangure, MexicoMaryam Abolhasani, IranMüge Sayitoğlu, TurkeyMutlu Arat, TurkeyMuzaffer Keklik, TurkeyNazan Sarper, TurkeyNejat Akar, TurkeyNeşe Yaralı, TurkeyNilgün Sayınalp, TurkeyPeter H. Wiernik, USARajive Kumar, IndiaSeok-Goo Cho, KoreaTahir Atik, TurkeyTülin Tiraje Celkan, TurkeyVanessa Innao, ItalyVasilios Berdoukas, ChinaVeysel Sabri Hançer, TurkeyVijay Kumar, IndiaWellington F. da Silva, BrazilZahit Bolaman, TurkeyZübeyde Nur Özkurt, TurkeyZühre Kaya, Turkey
- Page 1 and 2:
Volume 37 Issue 2June 2020E-ISSN: 1
- Page 4:
Multipl miyelom tedavisi içinETKİ
- Page 7 and 8:
Contact InformationEditorial Corres
- Page 9 and 10:
TURKISH JOURNAL OF HEMATOLOGYINSTRU
- Page 11 and 12:
important findings should be highli
- Page 13 and 14:
Full instructions and support are a
- Page 15:
Letters to the Editor125 Percentage
- Page 18 and 19:
Fodil M and Zemani F: Inhibitor Dev
- Page 20 and 21:
Fodil M and Zemani F: Inhibitor Dev
- Page 22 and 23:
Fodil M and Zemani F: Inhibitor Dev
- Page 24 and 25:
RESEARCH ARTICLEDOI: 10.4274/tjh.ga
- Page 26 and 27:
Okay M, et al: Splenic Marginal Zon
- Page 28 and 29: Okay M, et al: Splenic Marginal Zon
- Page 30 and 31: Okay M, et al: Splenic Marginal Zon
- Page 32 and 33: Wang H, et al: Bortezomib-based Reg
- Page 34 and 35: Wang H, et al: Bortezomib-based Reg
- Page 36 and 37: Wang H, et al: Bortezomib-based Reg
- Page 38 and 39: RESEARCH ARTICLEDOI: 10.4274/tjh.ga
- Page 40 and 41: Küçükcankurt F, et al: PTEN and
- Page 42 and 43: Küçükcankurt F, et al: PTEN and
- Page 44 and 45: RESEARCH ARTICLEDOI: 10.4274/tjh.ga
- Page 46 and 47: Li M, et al: Expression Profile of
- Page 48 and 49: Li M, et al: Expression Profile of
- Page 50 and 51: Li M, et al: Expression Profile of
- Page 52 and 53: Paviglianiti A: Metabolic Diseases
- Page 54 and 55: Paviglianiti A: Metabolic Diseases
- Page 56 and 57: BRIEF REPORTDOI: 10.4274/tjh.galeno
- Page 58 and 59: Çiftçiler R, et al: The Impact of
- Page 60 and 61: Çiftçiler R, et al: The Impact of
- Page 62 and 63: Safaei A, et al: Rare Chromosomal A
- Page 64 and 65: Kumar C, et al: Erythroblastic Isla
- Page 66 and 67: LETTERS TO THE EDITORTurk J Hematol
- Page 68 and 69: LETTERS TO THE EDITORTurk J Hematol
- Page 70 and 71: LETTERS TO THE EDITORTurk J Hematol
- Page 72 and 73: LETTERS TO THE EDITORTurk J Hematol
- Page 74 and 75: LETTERS TO THE EDITORTurk J Hematol
- Page 76 and 77: LETTERS TO THE EDITORTurk J Hematol
Change language